The AI-powered imaging diagnostics market is projected to grow significantly, reaching USD 9.73 billion by 2033, driven largely by advancements in artificial intelligence across various imaging modalities.
This market, which was valued at USD 1.97 billion in 2025, is expected to expand at a compound annual growth rate (CAGR) of 22.3% from 2026 to 2033. Key factors contributing to this growth include the rising demand for enhanced diagnostic accuracy and efficiency, as well as the integration of AI technologies in medical imaging, particularly in fields such as radiology, CT scans, MRI, and ultrasound. These technologies facilitate early disease detection, particularly for conditions like cancer and cardiovascular diseases.
Major players in this dynamic market include established companies like Philips and GE HealthCare, alongside innovative startups such as Qure.ai and DeepTek. These organizations are focusing on improving diagnostic workflows and patient outcomes through AI-driven solutions. The competitive landscape is characterized by rapid technological advancements, including deep learning and cloud-based imaging platforms, which are becoming integral to hospital information systems.
As the demand for accurate and scalable diagnostic solutions continues to rise, the market is likely to see intensified competition and further innovation. This trajectory suggests a promising future for AI-powered imaging diagnostics, with significant implications for healthcare efficiency and patient care.